1. Home
  2. CENT vs ZYME Comparison

CENT vs ZYME Comparison

Compare CENT & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$39.33

Market Cap

2.0B

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$24.06

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
ZYME
Founded
1955
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CENT
ZYME
Price
$39.33
$24.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$50.00
$32.75
AVG Volume (30 Days)
69.9K
494.4K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.81
EPS
N/A
N/A
Revenue
N/A
$76,304,000.00
Revenue This Year
$1.60
$63.10
Revenue Next Year
$2.04
$93.26
P/E Ratio
$15.73
N/A
Revenue Growth
N/A
0.38
52 Week Low
$28.77
$9.03
52 Week High
$41.25
$28.49

Technical Indicators

Market Signals
Indicator
CENT
ZYME
Relative Strength Index (RSI) 65.96 56.44
Support Level $31.65 $22.22
Resistance Level $40.81 $27.52
Average True Range (ATR) 1.44 0.87
MACD 0.12 0.18
Stochastic Oscillator 84.73 78.33

Price Performance

Historical Comparison
CENT
ZYME

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: